Background-Pseudomonas aeruginosa infection is uncommon in HIV infected patients and is usually nosocomially acquired and associated with risk factors such as neutropenia or central lines. We
Results
During the period of the study 617 patients were admitted for investigation of respiratory symptoms. Thirty eight of them (6%) had Ps aeruginosa respiratory infection; patient records were incomplete in one patient, and therefore we report the results in thirty seven patients. Thirty five patients were men, 34 were Caucasian homosexuals and one was an Indian recipient of a contaminated blood transfusion; the two women were heterosexual Africans. None used intravenous drugs and 15 were cigarette smokers, three were exsmokers. Their mean age was 35 years (range 25-56), none had diabetes mellitus nor heart 16 , of these two also had Kaposi's sarcoma, two also had Kaposi's sarcoma and cytomegalovirus (CMV) retinitis, and two disseminated Mycobacterium avium-intracellulare infection, (one of these also had CMV retinitis). Seven others had Kaposi's sarcoma (three with M avium-intracellulare), two had CMV retinitis and one had M avium-intracellulare. All were profoundly immunosuppressed: median CD4 count was 0-02 (range = 0-0.16) x 109'1 (normal range = 035-2.2 x 109'1). In four patients co-pathogens were identified; M aviumintracellulare in three (two community acquired infection) and Streptococcus pneumoniae in one (nosocomial infection).
Twenty-seven patients were taking antipneumocystis prophylaxis; co-trimoxazole in 18 (eight of whom were also taking zidovudine), nebulised pentamidine in five (three were also taking zidovudine), dapsone in three and IV pentamidine in one. Two other patients were taking zidovudine but no prophylaxis. One patient was receiving chemotherapy for Kaposi's sarcoma (table 1).
All patients had symptoms of cough, dyspnoea and fever, 27 had sputum expectoration and 2 had haemoptysis. Two distinct clinical presentations were seen; firstly, nine patients had a fulminant course presenting with a sepsis syndrome. In five of these patients infection was community acquired. Ps aeruginosa was also isolated from blood in two patients, blood and pleural fluid in one patient and pleural fluid in another patient. Despite treatment with antipseudomonal antibiotics, eight patients died. Three of the four patients with nosocomially acquired infection were receiving broad spectrum antibiotics at the time of diagnosis (table 1) .
Twenty eight patients had an indolent presentation with an onset of symptoms occurring over several days or weeks. Eighteen patients had a single episode of infection, but in 10 patients relapse occurred despite apparently successful treatment of the initial episode. Of the 18 patients with the single indolent episode infection was community acquired in 10.
Of eight with nosocomial infection four were receiving broad spectrum antibiotics for respiratory symptoms, one was receiving clindamycin for cerebral toxoplasmosis and one was receiving rifampicin, ciprofloxacin and clarithromycin for disseminated M aviumintracellulare infection (table 1) . Ps aeruginosa was also isolated from blood in one patient. Two patients were taking long term glucocorticoids, one as treatment for asthma the other to reduce oedema associated with disseminated Kaposi's sarcoma.
No antibiotic treatment for Ps aeruginosa was given to seven patients; all had advanced HIV disease with profound wasting and were terminally ill. Of 11 who received treatment Ten patients had one or more relapses, with the first occurring between 1 and 6 months (median = 2) after initial presentation. In nine of these the initial presentation was community acquired. Ps aeruginosa was also identified in blood in two patients and in pleural fluid in one other patient. Three patients were receiving rifampicin, ciprofloxacin and ethambutol as treatment for M avium-intracellulare infection and two others were receiving broad spectrum antibiotics as outpatients as treatment for presumed "bronchitis". Survival in this group was 1-18 (median = 8) months.
A wide range of radiographic abnormalities was seen in patients with both indolent and fulminant presentations (table 2, fig 1) . Of note, of 1 1 patients with alveolar consolidation appearances were classically lobar in two. Twelve of 15 16 patients had Ps aeruginosa pneumonia, infection was commu-nity-acquired in 15, four were neutropenic and mean CD4 count was 0.027 x 109/1. Three patients died and four had relapses." In contrast to these studies Baron and Hollander7 found that 16 of 1852 HIV positive patients (0 8%) attending an outpatient facility had Ps aeruginosa respiratory infection; all these patients had advanced HIV disease with a mean CD4 count of 0.025 x 109/1. As in our study they described two distinct syndromes: four of their patients had a fulminant sepsis syndrome; in two infection was community acquired and two were neutropenic. One patient died and all three who survived relapsed one or more times with further episodes of Ps aeruginosa infection. Twelve patients had an indolent presentation, in all infection was community acquired and none were neutropenic. One patient died rapidly with Kaposi's sarcoma and 9 of the remaining 11 patients had one or more relapses of infection.
In our study, although we did not document serological evidence of invasive pulmonary disease, the absence of other pathogens in respiratory fluid and the resolution of symptoms and radiographic infiltrates in those treated with antipseudomonal antibiotics argue strongly that our patients had infection and were not simply colonised by Ps aeruginosa. Several of our patients had risk factors traditionally associated with Ps aeruginosa infection, including neutropenia in 14 patients and indwelling central venous lines in five, but 13 patients, over one third of our study population, had no traditional risk factors. We looked for other associations, in the absence of traditionally associated risk factors. Fourteen of our patients were receiving broad spectrum antibiotics and 21 were receiving systemic anti-pneumocystis prophylaxis; these antibiotics may have encouraged development of pseudomonas infection. Although nebulisers are a recognised source of colonisation by pseudomonas of the upper respiratory tract the majority of our patients were not receiving nebulised pentamidine as anti-pneumocystis prophylaxis, in contrast to the study by Schuster and Norris, where 25% of patients were receiving this form of prophylaxis.' l In our patients prolonged survival with immunosuppression was probably an important factor for development of pseudomonas respiratory infection. All of our patients had late stage HIV disease with very low CD4 counts; some were terminally ill. In addition 16 of our patients had previous episodes of pneumocystis pneumonia. This infection is known to leave residual parenchymal lung damage and bronchiectasis following recovery, which might predispose to acquisition of pseudomonas. Four of our patients had bronchiectasis, two following P carinii pneumonia. We did not perform CT of the chest in our patients but the finding of bronchial wall thickening on plain chest radiography in 13 patients suggests that we may have underestimated the frequency of bronchiectasis. In contrast to Baron and Hollander's study, 7 where only one patient had sinus disease, 60% of our patients had symptomatic sinus disease. Sinus disease occurs with increased frequency in HIV infected individuals.'2 In patients with advanced immunosuppression, and CD4 counts below 0-02 x 109/1 the prevalence ranges from 1.2%-6 3%,"3'4 and Ps aeruginosa is a common pathogen.'314 The prevalence of paranasal sinus abnormalities on cranial MRI is even higher; 15. 1% of patients with AIDS scanned for suspected intracranial pathology had evidence of moderate or severe sinus disease (>75% obliteration of > 1 sinus). In addition there was a correlation between the degree of immunosuppression and the mean maximum mucosal thickening (indicative of chronic sinusitis) being worse in patients with AIDS than in HIV positive patients without AIDS. '5 It is not clear whether the sinus is acting as a nidus for infection or whether there is diffuse abnormality of the respiratory tract mucosa in advanced HIV infection, which in some way permits infection with Ps aeruginosa. In view of the high rate of relapse in our patients and in those reported by Baron and Hollander it is tempting to suggest that long term maintenance anti-pseudomonal therapy might be indicated in those with relapsing infection. This form of therapeutic intervention is already used in non-HIV infected patients with cystic fibrosis who have pseudomonas respiratory tract infection and has been shown to reduce the frequency and severity of recurrent infection. '6 We observed a wide variety of radiographic abnormalities associated with Ps aeruginosa infection in our patients, but no specific pattern was identified. Indeed many of those with diffuse interstitial changes were thought to have pneumocystis pneumonia. Thus Ps aeruginosa is an important diagnosis to consider in patients presenting with symptoms and chest radiographic abnormalities suggestive of P carinii pneumonia. Similarly the finding of lobar consolidation means pseudomonas infection should be considered in the infectious differential diagnosis of pneumococcal infection.2 In the study by Schuster and Norris,"1 six of their sixteen patients had lobar infiltrates and eight had cavitatory infiltrates on admission; cavitation occurred in a further three patients. Surprisingly three of our patients had upper lobe thick-wall cavitatory lesions reminiscent of M tuberculosis infection, suggesting invasive local disease with parenchymal destruction. In Baron and Hollander's study all patients with a fulminant presentation had alveolar consolidation as did eight with an indolent course; only two patients had interstitial infiltrates and two had normal radiographs; none of the patients had cavitation.7 In the study from Milan'0 all 20 patients had interstitial infiltrates and eight also had cavitation and four had effusions. Interpretation of these findings is difficult because 14 patients had copathogen infections which may have contributed to the radiographic abnormalities. We found a high rate of complications in our patients, in contrast to previous reports which suggest empyema is uncommon in HIV infected patients with pyogenic bacterial pneumonia,'7 empyema occurred in three of our patients.
In conclusion Ps aeruginosa respiratory infection is seen with increased frequency in patients with advanced HIV infection and AIDS. Two distinct patterns of presentation are seen, a fulminant sepsis syndrome and an indolent course. The radiographic abnormalities are non specific and may mimic pneumocystis pneumonia. In a significant proportion of patients infection is community acquired and in those with an indolent course there is a high rate of relapse. Although two thirds of patients have traditionally associated risk factors, in the remainder advanced HIV induced immunosuppression, use of systemic antipneumocystis prophylaxis or broad spectrum antibiotics, and symptomatic sinus disease appear to be important risk factors. Other factors that may be important, and require further study, include Ps aeruginosa-produced elastase, slime layer, exotoxin A and mucoid exopolysaccharide (MEP), and HIV-induced defects of intrapulmonary anti-elastase activity and failure of production of opsonic antibodies directed to Ps aeruginosa MEP. Ps aeruginosa should be considered in the differential diagnosis of new respiratory symptoms in patients with advanced HIV disease.
